During the past decade, Illinois Eye Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois Eye Institute" #1 sponsor was "Heidelberg Engineering GmbH" with 2 trials, followed by "Illinois College of Optometry" with 2 trials sponsored, "Alexandra Bowers" with 1 trials sponsored, "Optovue" with 1 trials sponsored and "SOLX, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois Eye Institute" #1 collaborator was "Chadwick Optical Inc." with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "Wesley Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Illinois Eye Institute" are "Glaucoma" (3 trials), "Keratoconus" (2 trials), "Allergy" (1 trials), "Dry Eye" (1 trials) and "Glaucoma, Open Angle" (1 trials). Many other conditions were trialed in "Illinois Eye Institute" in a lesser frequency.

Most popular intervention types in "Illinois Eye Institute" are "Device" (5 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Corneal gas permeable lens" (1 trials), "Heidelberg Spectralis OCT" (1 trials), "High power (57 prism diopter) peripheral prism glasses" (1 trials), "Loteprednol Etabonate 0.38% Ophthalmic Gel/Jelly" (1 trials) and "Low power sham peripheral prism glasses" (1 trials). Other intervention names were less common.

The vast majority of trials in "Illinois Eye Institute" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Illinois Eye Institute". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Illinois Eye Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Illinois Eye Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".